(Q34624101)

3 August 2017

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients (English)

1 reference

3 August 2017

Hui Li

1

1 reference

3 August 2017

Jin-Pu Yu

2

1 reference

3 August 2017

Shui Cao

3

1 reference

3 August 2017

Feng Wei

4

1 reference

3 August 2017

Peng Zhang

5

1 reference

3 August 2017

Xiu-Mei An

6

1 reference

3 August 2017

Zong-Tang Huang

7

1 reference

3 August 2017

Xiu-Bao Ren

8

1 reference

3 August 2017

28 April 2007

1 reference

Journal of Clinical Immunology

3 August 2017

1 reference

3 August 2017

27

1 reference

3 August 2017

3

1 reference

3 August 2017

317-326

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-007-9076-0

3 August 2017

0 references

cites work

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-007-9076-0

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

21 January 2018

1 reference

12 December 2020

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

1 reference

12 December 2020

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

12 December 2020

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma

1 reference

12 December 2020

TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

1 reference

12 December 2020

Human CD4+ CD25+ regulatory T cells suppress NKT cell functions

1 reference

12 December 2020

The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer

1 reference

12 December 2020

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

1 reference

12 December 2020

Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients

1 reference

12 December 2020

Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression

1 reference

12 December 2020

10.1007/S10875-007-9076-0

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference